Lucid Diagnostics Inc.
LUCD
$1.01
$0.022.07%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 23.03% | 8.28% | 5.01% | 14.74% | 39.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.03% | 8.28% | 5.01% | 14.74% | 39.89% |
| Cost of Revenue | -3.56% | -6.03% | 8.48% | 9.13% | 11.07% |
| Gross Profit | 42.89% | 28.62% | -15.02% | -0.82% | 14.88% |
| SG&A Expenses | 8.28% | 13.54% | 12.42% | 15.14% | 17.74% |
| Depreciation & Amortization | -0.24% | -10.83% | -57.65% | -69.80% | -76.53% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.78% | 7.83% | 6.25% | 8.13% | 8.30% |
| Operating Income | -3.18% | -7.79% | -6.37% | -7.57% | -6.21% |
| Income Before Tax | 27.20% | -27.41% | -18.89% | -18.44% | -31.46% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 27.20% | -27.41% | -18.89% | -18.44% | -31.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 27.20% | -27.41% | -18.89% | -18.44% | -31.46% |
| EBIT | -3.18% | -7.79% | -6.37% | -7.57% | -6.21% |
| EBITDA | -3.27% | -8.65% | -8.18% | -10.52% | -10.08% |
| EPS Basic | 60.81% | 23.35% | 20.76% | 14.63% | 5.87% |
| Normalized Basic EPS | 51.45% | 44.16% | 35.77% | 25.72% | 18.05% |
| EPS Diluted | 60.81% | 23.35% | 20.76% | 14.63% | 5.87% |
| Normalized Diluted EPS | 51.45% | 44.16% | 35.77% | 25.72% | 18.05% |
| Average Basic Shares Outstanding | 112.02% | 101.68% | 79.82% | 55.87% | 31.99% |
| Average Diluted Shares Outstanding | 112.02% | 101.68% | 79.82% | 55.87% | 31.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |